Mannkind reported $280.73M in Debt for its third fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Debt Change
Acceleron Pharma XLRN:US $ 0M 0M
Adamas Pharmaceuticals ADMS:US 129.04M 671K
Adma Biologics ADMA:US $ 94.36M 0.49M
Biocryst Pharmaceuticals BCRX:US $ 304.16M 10.51M
Biodelivery Sciences International BDSI:US $ 58.72M 19.91M
Chemocentryx CCXI:US $ 23.57M 0.98M
Dicerna Pharmaceuticals DRNA:US $ 0M 0M
Dynavax Technologies DVAX:US $ 220.22M 0.26M
Eli Lilly And LLY:US $ 17085.4M 570.3M
Flexion Therapeutics FLXN:US $ 250.5M 28.96M
Halozyme Therapeutics HALO:US $ 875.7M 0.97M
Insmed INSM:US $ 572.61M 8.59M
JAZZ PHA JAZZ:US $ 6285.05M 459.25M
Karyopharm Therapeutics KPTI:US $ 301.57M 195K
Kindred Biosciences KIN:US $ 19.87M 0.13M
Macrogenics MGNX:US $ 0M 0M
Mannkind MNKD:US $ 280.73M 4.4M
Minerva Neurosciences NERV:US $ 0M 0M
Novavax NVAX:US $ 427.09M 3.23M
Novo Nordisk A Fs NVO:US $ 13748M 16M
Peregrine Pharmaceuticals PPHM:US $ 141.83M 3.01M
Xencor XNCR:US $ 0M 0M